AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
TheraPEAK® AmpliCell® Recombinant Cytokines – IL‑21, 100 µg
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
-
4D-Nucleofector® LV UnitLet's Expedite Your Next Scale in Transfection
-
Instructions - 4D-Nucleofector™ LV Unit Inspection EquipmentHow to use the inspection equipment for testing the functionality of the 4D-Nucleofector™ LV Unit
-
Metabolism_Brochure_CoBrand_FormThis is a co-marketing form for distributors. There is a restricted space on the cover next to the Lonza logo and on the back below the market bar. Art for placement MUST be a PDF. In addition there is space on the back cover for a web address at the top and contact and disclaimers. Please look for the instruction PDF in the literature DB Article number CD-FO006Inst
-
A Novel, Chemically Defined, Serum-Free Cell Culture Medium for Expansion of Transfected T CellsIn this study, we present data generated with TheraPEAK® T-VIVO®, a novel, chemically defined, non-animal origin cell culture medium utilized to grow T cells in the absence of serum, before and after transfection with the Nucleofector® Technology.
-
Webinar – Efficient Transfection of Biologically Relevant Cells in Immunology Research (pdf)Lonza_Webinars_Webinar__Efficient_Transfection_of_Biologically_Relevant_Cells_in_Immunology_Research.pdf
-
How it works - Video Tutorial - X UnitThe video shows the workflow for Nucleofection using the 4D-Nucleofector X Unit.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
Next Generation 4D-Nucleofector® System Toss SheetSee at-a-glance product characteristics of the next generation 4D-Nucleofector System, including Core Unit, X Unit, Y Unit, LV Unit and 96-well Unit descriptions, data about transferability of Nucleofection conditions and ordering information.
-
4D-Nucleofector® LV Unit PRONext-generation large-scale electroporation from research to GMP manufacturing
-
4D-Nucleofector® Manual – First GenerationComprises instructions for all first generation units